about
Ventricular repolarization measures for arrhythmic risk stratificationGenome-wide association analysis identifies 13 new risk loci for schizophreniaResting-state high-frequency heart rate variability is related to respiratory frequency in individuals with severe mental illness but not healthy controls.All-cause mortality among people with serious mental illness (SMI), substance use disorders, and depressive disorders in southeast London: a cohort study.Autonomic modulation and health-related quality of life among schizophrenic patients treated with non-intensive case managementDifferential cardiac effects of aerobic interval training versus moderate continuous training in a patient with schizophrenia: a case report.The phrenic component of acute schizophrenia--a name and its physiological reality.The genomics of schizophrenia: update and implications.Olanzapine-induced weight gain plays a key role in the potential cardiovascular risk: evidence from heart rate variability analysis.High-resolution joint symbolic analysis to enhance classification of the cardiorespiratory system in patients with schizophrenia and their relatives.Antipsychotic drugs and the risk of ventricular arrhythmia and/or sudden cardiac death: a nation-wide case-crossover study.Premature death in adults with 22q11.2 deletion syndrome.Interventions for the metabolic syndrome in schizophrenia: a reviewConcomitant medication of psychoses in a lifetime perspective.Antipsychotic Drugs Inhibit Platelet Aggregation via P2Y 1 and P2Y 12 ReceptorsDrug-induced Inhibition and Trafficking Disruption of ion Channels: Pathogenesis of QT Abnormalities and Drug-induced Fatal Arrhythmias.The prevalence and mechanisms of metabolic syndrome in schizophrenia: a review.'Natural' and 'Unnatural' medical deaths and coronial law: A UK and international review of the medical literature on natural and unnatural death and how it applies to medical death certification and reporting deaths to coroners: Natural/Unnatural dCardiovascular Disease in Clozapine-Treated Patients: Evidence, Mechanisms and Management.Obstructive sleep apnea: Underestimated risk factor in sudden cardiac death in schizophrenia.Psychotropic medications and the risk of sudden cardiac deathThe toxicology and comorbidities of fatal cases involving quetiapine.Cardiovascular risk assessment of atypical antipsychotic drugs in a zebrafish model.An epidemiologic and clinical overview of medical and psychopathological comorbidities in major psychoses.Sudden cardiac death with stress and restraint: The association with sudden adult death syndrome, cardiomyopathy and coronary artery disease.Reduced heart rate variability in schizophrenia and bipolar disorder compared to healthy controls.Serum levels of magnesium in sudden cardiac deaths among people with schizophrenia: hit or miss?Psychotropic medications and the risk of sudden cardiac death during an acute coronary event.Effects of long-acting injectable antipsychotics versus oral antipsychotics on autonomic nervous system activity in schizophrenic patientsMetabolic Syndrome among Schizophrenic Patients: A Comparative Cross-Sectional Study in the Middle Belt of Ghana
P2860
Q26769982-4E424BC3-EA80-4855-99BF-DE1E01D41A1EQ28297287-A71B133B-C2C3-48C3-ADEE-22B227CEB7DAQ30828935-93239994-08CC-4608-93A9-AC810B008671Q33710004-07B5DFA0-356F-4FD5-9F3E-DAD87F03BCB0Q34071551-1E957AF5-C6DF-47F0-A2A1-9DCECBDE2634Q34106281-3719EA2E-C465-45E2-9B89-AB3273F61B30Q34206261-1B6AD05C-20DD-457D-A249-7306730A0D6AQ34381708-617765E2-7CBE-4FBE-B726-1555D5120FB7Q34659378-7B4C3FA6-305E-4A31-8B87-D30C0925C37DQ34802708-1C7EEC73-DE50-4B26-9AF4-6722C0E88BB8Q35135720-25526D47-0E22-4FD1-A6CE-987B6E05B55DQ35281099-9B4813DA-674C-442C-9420-A9D1CC8A011DQ36401248-77E38883-3A97-43FF-A369-EBEF7DA21AD6Q36420453-0D46C9C3-B23B-45E8-8C81-BDF139436627Q36741206-D23DC87D-D74F-4AB0-98BD-D4BE01373E2AQ36886266-D798CA5C-EC24-419C-813B-CA617A8D48B6Q37079080-ACF4AADA-3117-4D71-BCC6-10BA5D4A649DQ39409451-C81F38AC-1694-4D18-9969-58C1AA1342BAQ40082921-E4ACB386-3332-4AC2-83E1-49D37EB2C17EQ42395447-48969C3A-47C9-4981-86A9-ACC588766373Q42732569-8146FD7A-C326-49EC-8A89-05E6B25F7518Q46114930-19F5F365-A82A-429F-A916-B50D86F057C7Q46591770-CA48DE07-0B5A-4EA5-8B74-0E78666C9460Q48908840-02EDB3EE-45F0-4843-A50F-0FA6DA146416Q50048242-D310FE17-CAF0-4964-9783-FEAFB2A5513EQ50567316-8543CA01-24F0-4427-B057-C74C72993C52Q50739721-F189A905-A618-4808-9E29-93A7F8333563Q50786861-28E2E019-D728-4FE3-A84F-29171D54BC36Q57074533-2F19A617-AF33-4B76-89D3-38BA7A568E16Q58969472-4B16C78A-F53E-4006-95F3-BAC3C4264EE1
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Schizophrenia and sudden cardiac death: a review.
@en
Schizophrenia and sudden cardiac death: a review.
@nl
type
label
Schizophrenia and sudden cardiac death: a review.
@en
Schizophrenia and sudden cardiac death: a review.
@nl
prefLabel
Schizophrenia and sudden cardiac death: a review.
@en
Schizophrenia and sudden cardiac death: a review.
@nl
P2093
P2860
P1476
Schizophrenia and sudden cardiac death: a review.
@en
P2093
Antti Alaräisänen
Hannu Koponen
Heikki Huikuri
Kaisa Saari
M J Pekka Raatikainen
Markku Savolainen
Olavi Pelkonen
P2860
P304
P356
10.1080/08039480801959323
P577
2008-01-01T00:00:00Z